Nano-X Imaging Reports Q2 2025 Financial Results

Nano-X Imaging Ltd. ( (NNOX) ) has released its Q2 earnings. Here is a breakdown of the information Nano-X Imaging Ltd. presented to its investors.

Nano-X Imaging Ltd., a company specializing in innovative medical imaging technology, has released its financial results for the second quarter of 2025, highlighting its progress in system deployment and strategic partnerships. The company reported a revenue increase to $3.0 million from $2.7 million in the same quarter of 2024, driven by growth in its Nanox.ARC system sales and teleradiology services. Despite the revenue growth, the company experienced a net loss of $14.7 million, slightly higher than the previous year’s $13.6 million loss, attributed to increased finance expenses. Key developments include the expansion of the Nanox.ARC installed base, the submission of a new software module to the FDA, and the signing of a volume supply agreement with Fabrinet to support production scalability. Looking ahead, Nanox remains focused on meeting its year-end system deployment targets and enhancing its product offerings to align with market needs, while navigating financial challenges.